People

Kasper Roet

quralis.com

Kasper Roet, PhD, is a co-founder and CEO of QurAlis, developing precision therapies for ALS and related neurodegeneration. He also co-founded EnClear Therapies and trained in neurobiology at the Netherlands Institute for Neuroscience, VU Amsterdam and Harvard; his research combines patient-derived stem-cell models with therapeutic target discovery.